Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Evidence-Based Drug Therapy Update (MUSC, Charleston)


Evidence-Based Drug Therapy Update
Hosted by the Medical University of South Carolina
 
Thursday, May 24th - Saturday, May 26th, 2018
 
Crowne Plaza Hotel
4831 Tanger Outlet Blvd
North Charleston, SC
 
 
BROCHURE AND LEARNING OBJECTIVES:  Click here to view.  Details for each session may also be found by expanding each session below.
 
REGISTRATION:
  • Online: Visit www.musc.edu/cme and select “CME Conferences” on the left hand side, then scroll down to find this activity, select the blue “Register” button, and follow directions as prompted
  • By Mail:  Mail registration form (found on page six of the brochure - click here) with check made out to “Medical University of South Carolina” or credit card information to Elizabeth Gossen, Office of CME, Medical University of South Carolina, 96 Jonathan Lucas Street, HE221A, MSC 754, Charleston, SC, 29425
  • Telephone: (843) 876-1925 – Registration by credit card only
  • Fax: (843) 876-1931 – Registration by credit card only
 

Date: May 24, 2018 07:15 AM - May 26, 2018 12:15 PM

CE Hours

18.00

CE Units

1.800

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Medical University of South Carolina

Requirements for CE Credit

To claim credit for a session, participants must sign-in at and attend the entire session.  Participants must complete online evaluations (providing their correct NABP e-profile number and day/month of birth) in order to have credit reported to the NABP CPE Monitor.  Evaluations should be completed and credit claimed within 30 days of the live program to ensure transmission to the NABP CPE Monitor.  The NABP CPE Monitor will not accept any credit claimed and transmitted greater than 60 days from the date of the live program.
 
To verify your NABP e-Profile number and day/month of birth on record with NABP, please visit their website by selecting the link below.

 

 

 

 

At the completion of this activity, the participant will be able to:
  1. Describe the current data on the use and abuse of opioids in the US
  2. Accurately assess patients with pain for consideration of an opioid trial
  3. Establish realistic goals for pain management and restoration of function
  4. Initiate and titrate opioid treatment (IR and ER/LA) safely and judiciously, maximizing efficacy while minimizing risks
  5. Monitor and re-evaluate treatment continuously; discontinue safely when appropriate
  6. Counsel patients and caregivers about use, potential adverse effects, misuse, abuse, diversion and overdose
  7. Educate patients about safe storage and disposal of opioids

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, BCPS, FASHP, FAPhA
Professor of Clinical Pharmacology & Outcomes Science; Professor of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-137-L01-P
Date: 05/24/18 08:00 AM - 05/26/18 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Recall the 2017 ACC/AHA hypertension guideline new definition of hypertension and how it changes the US population at risk for hypertension
  2. Recognize how to properly take BP and the importance of accurate BP measurement
  3. Recognize when to implement lifestyle modification in the treatment of hypertension
  4. Recall the current first-line agents for the treatment of hypertension
  5. Recognize what BP goal (target) is recommended to best improve CV outcome in specific patient populations with hypertension

Speaker(s)/Author(s)

Jan Basile, MD
Professor of Medicine, Seinsheimer Cardiovascular Health Program, MUSC; Raph H Johnson VA Medical Center

Activity Number

0062-9999-18-053-L01-P
Date: 05/24/18
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Identify symptoms and signs that suggest the presence of NAFLD
  2. Recognize sequelae of chronic NAFLD
  3. Describe the basic foundations of NAFLD treatment 

Speaker(s)/Author(s)

Don C. Rockey, MD
Professor, Division of Gastroenterology & Hepatology; Chairman, Dept of Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-054-L01-P
Date: 05/24/18
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Demonstrate how to effectively use language that is sensitive to the needs and experiences of transgender individuals
  2. Perform primary and preventive care for transgender patients

Speaker(s)/Author(s)

Marty Player, MD
Associate Professor, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-055-L01-P
Date: 05/24/18
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Review newer antidepressants and their role in therapy
  2. Discuss important considerations in the selection of antidepressant therapy
  3. Summarize evidence-based recommendations to optimize treatment outcomes
  4. Apply presented data and clinical pearls to a patient case

Speaker(s)/Author(s)

Sophie Robert, BPharm, PharmD, BCPP
Clinical Pharmacy Specialist in Psychiatry; Research Assistant Professor, Dept of Psychiatry & Behavioral Sciences; Adjunct Assistant Professor, MUSC College of Pharmacy, Medical University of South Carolina

Activity Number

0062-9999-18-056-L01-P
Date: 05/24/18
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Recognize and apply the collaborative, patient-centered spirit of MI (acronym:  RULE) to medication adherence
  2. Recognize and apply specific MI communication skills (acronym:  OARS) to medication adherence

Speaker(s)/Author(s)

John Freedy, MD, PhD
Associate Professor, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-057-L04-P
Date: 05/24/18
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Engage in shared decision-making conversations regarding prostate cancer in higher-risk men
  2. Discuss prostate cancer disparities with patients
  3. Access United States Preventive Services Task Force prostate cancer screening guidelines
  4. Manage or appropriately refer abnormal prostate screening results
  5. Discuss prostate cancer treatments with specialist colleagues

Speaker(s)/Author(s)

Nicholas Shungu, MD
Assistant Professor, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-060-L01-P
Date: 05/24/18
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the participant will be able to:
  1. Describe distinguishing characteristics among currently available stimulant preparations
  2. List notable potential risks and benefits of utilizing stimulants for various diagnoses encountered in the primary care setting including: ADHD, depression, apathy, and narcolepsy
  3. Apply presented information and clinical pearls to select appropriate pharmacotherapy and monitoring parameters

Speaker(s)/Author(s)

Clint Ross, PharmD, BCPP
Clinical Pharmacy Specialist in Psychiatry; Psychiatric Pharmacy Residency Program Director; Adjunct Assistant Professor, MUSC College of Pharmacy, MUSC

Activity Number

0062-9999-18-059-L01-P
Date: 05/25/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Assess the available guidelines for tobacco cessation
  2. Evaluate the effectiveness and safety of medications used in the treatment of tobacco use disorder based on the latest clinical trials and extant evidence
  3. Discuss the use of electronic nicotine delivery systems (ENDS) in tobacco cessation, based on the new National Academy of Medicine report
  4. Identify cessation resources available on-line and in the community

Speaker(s)/Author(s)

Katherine Hoover, PharmD, BCPS
Clinical Pharmacy Specialist, Ambulatory Care, Medical University of South Carolina

Activity Number

0062-9999-18-058-L01-P
Date: 05/25/18
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Interpret spirometry
  2. Adjust medication classes on the basis of both symptoms and exacerbation frequency
  3. Improve medication compliance in their patients by better understanding the definition of an exacerbation
  4. Determine when a CT scan is indicated for obstructive lung diseases 

Speaker(s)/Author(s)

Charles Strange, MD
Professor, Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-061-L01-P
Date: 05/25/18
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Incorporate spirometry into the definition of asthma to improve the specificity of diagnosis
  2. Discuss with patients the removal of boxed warnings from some inhalers but not others regarding increased risk of asthma death
  3. Develop a checklist for patients who are poorly controlled on current asthma therapy
  4. Determine when to refer patients for omalizumab, mepulizamab, and benralizumab injections

Speaker(s)/Author(s)

Charles Strange, MD
Professor, Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-062-L01-P
Date: 05/25/18
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Identify the appropriate use of HRT
  2. Discuss the timing of HRT and its safety
  3. Recognize the risks of HRT

Speaker(s)/Author(s)

Donald Fylstra, MD
Professor, Department of Obstetrics and Gynecology, Medical University of South Carolina

Activity Number

0062-9999-18-063-L01-P
Date: 05/25/18
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Select appropriate treatment options for patients with glaucoma and other common ophthalmic conditions
  2. Design a treatment plan for an adult and pediatric patient with an ophthalmic condition
  3. List side effects and important counseling points for ophthalmic medications

Speaker(s)/Author(s)

Morgan Adams, PharmD, BCACP
Assistant Professor, Dept of Family & Preventive Medicine, University of South Carolina School of Medicine

Activity Number

0062-9999-18-064-L01-P
Date: 05/25/18
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Discuss treatment considerations in migraine
  2. Describe pathophysiology of migraine yesterday and today

Speaker(s)/Author(s)

Aljoeson Walker, MD
Associate Professor, Department of Neurology, Medical University of South Carolina

Activity Number

0062-9999-18-052-L01-P
Date: 05/25/18 04:00 PM - 05/24/18 05:00 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the participant will be able to:
  1. Address the barriers and difficulties encountered while staying current with new medical data and trends
  2. Evaluate traditional and modern resources that simplify information gathering
  3. Discuss technology's impact on continuing education
  4. Explore new opportunities available for professionals seeking to provide education in their field.

Speaker(s)/Author(s)

Michael Corvino, PharmD
Adjunct Assistant Professor (CSU Physician Assistant Program); Diabetes Educator (Palmetto Pharmacist Network), Pharmacy Manager (Walgreens)

Activity Number

0062-9999-18-066-L04-P
Date: 05/26/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Identify and evaluate new FDA-approved type 2 diabetes mellitus agents and recent literature regarding type 2 diabetes mellitus
  2. Compare and contrast the latest type 2 diabetes mellitus agents and literature findings with current standards of care
  3. Integrate recent evidence-based recommendations into clinical practice

Speaker(s)/Author(s)

Emmeline Tran
Assistant Professor, Department of Clinical Pharmacy & Outcomes Sciences, MUSC College of Pharmacy

Activity Number

0062-9999-18-067-L01-P
Date: 05/26/18
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Recognize common dermatologic conditions and their treatments 

Speaker(s)/Author(s)

Richard Marchell
Associate Professor; Department of Dermatology & Dermatologic Surgery, Medical University of South Carolina

Activity Number

0062-9999-18-068-L01-P
Date: 05/26/18
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Identify intervals to draw labs and consult nephrology
  2. Manage common complications of chronic kidney disease
  3. Minimize decline in renal function with chronic kidney disease

Speaker(s)/Author(s)

Scott Bragg, PharmD, BCPS
Assistant Professor, MUSC College of Pharmacy & Dept of Family Medicine

Activity Number

0062-9999-18-065-L01-P
Date: 05/26/18 11:15 AM - 05/25/18 12:15 AM

CE Hours

1.00